incretin mimetic agents glp 1 receptor agonists Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus GLP1-GIP receptor co-agonists: a promising

Conduct a claims impact analysis (a good broker can model this for you) This should include: Historic GLP-1 utilization

In vitro studies suggest that may enhance endometrial receptivity by improving insulin signaling and inflammatory status in endometrial cells, thereby upregulating the expression of implantation-related molecules such as integrins (84, 86, 92)

Exendin has a short half-life

PMID: 24762441

Metformin received FDA approval in 1994 for type 2 diabetes and with its beneficial effect on glycated hemoglobin (HbA1c), efficacy, and safety being wellestablished, 3 , 4 , 5 it became the recommended firstline choice for patients with type 2 diabetes in 2005